Consensus MedinCell S.A.

Equities

MEDCL

FR0004065605

Real-time Euronext Paris Other stock markets 11:35:14 2024-04-30 EDT			5-day change	1st Jan Change
14.36 ^EUR	+4.06%		+24.22%	+99.44%

04-17	Medincell: share price rises following agreement with AbbVie	CF
04-16	Medincell, AbbVie to Co-Develop Injectable Therapeutics	DJ

Evolution of the average Target Price on MedinCell S.A.

Price target over the last 5 years

History of analyst recommendation changes

e82efda840d0822.Tvnls3lF2YjANo0RJeoHIN2zz4jhxSY28Grz3pVy1lU.eb-oySsxi_mnQvgnS6JjdrPquuWboUpbu0eBh9cfhWImzaDpEiyr0pFa2A~231b725a656c83c475ba26a336e8cec4

Analyst Recommendations on MedinCell S.A.

MedinCell: share price surges, broker in support	23-03-21	CF
MEDINCELL : Oddo raises its target price on the stock	23-03-21	CF

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.36 EUR

Average target price

17.15 EUR

Spread / Average Target

+19.43%

High Price Target

22 EUR

Spread / Highest target

+53.20%

Low Price Target

14 EUR

Spread / Lowest Target

-2.51%

Consensus detail

Consensus revision (last 18 months)

Ratings for MedinCell S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar